CATHERINE LEBEAU: Open Payments
NPI 1033973946 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,005 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 1 | $141 |
| Lilly USA, LLC | 2 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Janssen Biotech, Inc. | 2 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $41 |
| PFIZER INC. | 1 | $29 |
| Fidia Pharma USA Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
Products named: Bimzelx, TALTZ, COSENTYX, Sotyktu, TREMFYA, CIBINQO, ILUMYA, BLU-U.
Industry payments across FL — which companies pay providers there.
